Abiopharma

🔍 Rankin Lynne T (Executive)

Company: Hamilton Beach Brands Holding Co (HBB)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 590 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 17,125.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Sold 2,780 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 14,345.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Acquired 5,561 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 23,991.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Acquired 5,561 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 24,286.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Acquired 4,171 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 17,026.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Acquired 4,171 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 16,641.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Holds 1,724 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 1,724.00 | Footnotes: F1, F1, F1

Footnotes:

• F1: N/A
• F2: Reporting Person disclaims beneficial ownership of all such shares.